Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vitamin K Antagonist”

140 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 140 results

Post-approval studies (Phase 4)Active Not RecruitingNCT03129555
What this trial is testing

The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE)

Who this might be right for
Deep Vein ThrombosisPulmonary Embolism
Herlev and Gentofte Hospital 5,000
Large-scale testing (Phase 3)Looking for participantsNCT04284839
What this trial is testing

The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial

Who this might be right for
Bleeding Post Cardiac SurgeryIndication for Anticoagulation
Population Health Research Institute 3,500
Large-scale testing (Phase 3)Study completedNCT02866175
What this trial is testing

Edoxaban Treatment Versus Vitamin K Antagonist in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

Who this might be right for
Atrial Fibrillation
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 1,506
Not applicableStudy completedNCT02960880
What this trial is testing

Real-world Comparative Effectiveness of Stroke Prevention in Patients With Atrial Fibrillation Treated With Rivaroxaban vs. Vitamin k Antagonists

Who this might be right for
Atrial Fibrillation
Bayer 99,999
Post-approval studies (Phase 4)Study completedNCT02066662
What this trial is testing

Rivaroxaban Compared to Vitamin K Antagonist Upon Development of Cardiovascular Calcification

Who this might be right for
Atrial Fibrillation or Pulmonary EmbolismNeed of Long Term Oral Anticoagulation Therapy (OAT)Existent Coronary or Valvular Calcification, or Both and Agatston Score > 50 in at Least One Location
RWTH Aachen University 192
Not applicableStudy completedNCT03047603
What this trial is testing

Evaluation of Diagnostic Efficiency of PIVKA-II and Other Tumor Markers in HCC

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 4,005
Post-approval studies (Phase 4)Looking for participantsNCT06402851
What this trial is testing

Vitamin K AntagonISt, Factor Xa Inhibitor or No Anticoagulation in Atrial Fibrillation and DIalytic End-stage Renal DiseasE (VISIONAIRE)

Who this might be right for
Atrium; FibrillationChronic Kidney Diseases
Hospital Sirio-Libanes 1,500
Not applicableStudy completedNCT01809015
What this trial is testing

Evaluation of Oral Anticoagulation With Vitamin K Antagonists - The thrombEVAL Study Programme

Who this might be right for
Anticoagulant Antagonists, Vitamin K and Other Coagulants Causing Adverse Effects in Therapeutic UseAtrial FibrillationVenous Thromboembolism
Johannes Gutenberg University Mainz 2,318
Large-scale testing (Phase 3)Not Yet RecruitingNCT07471139
What this trial is testing

SWITCH: Apixaban vs Vitamin K in HM3

Who this might be right for
LVAD (Left Ventricular Assist Device) ThrombosisHeart FailureBleeding+3 more
Columbia University 460
Not applicableStudy completedNCT03826927
What this trial is testing

New Oral Anticoagulants (NOAC) in Stroke Patients

Who this might be right for
StrokeAtrial Fibrillation
University Hospital, Basel, Switzerland 1,023
Not applicableStudy completedNCT00266045
What this trial is testing

D-dimer Levels During and After Anticoagulation in Patients With a Previous Venous Thromboembolism: Effects on the Risk of Recurrence

Who this might be right for
Deep Vein ThrombosisPulmonary Embolism
IRCCS Azienda Ospedaliero-Universitaria di Bologna 355
Large-scale testing (Phase 3)Study completedNCT02832544
What this trial is testing

INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Non-Inferiority

Who this might be right for
Rheumatic Heart Disease
Population Health Research Institute 4,565
Post-approval studies (Phase 4)Study completedNCT04437654
What this trial is testing

The Efficacy and Safety of Non-vItamiN K antaGonist oraL Anticoagulants for intermEdiate Stroke Risk in Patients With Atrial Fibrillation (SINGLE-AF)

Who this might be right for
Atrial Fibrillation Patients With Intermediate Stroke Risk
Yonsei University 1,803
Not applicableLooking for participantsNCT05333666
What this trial is testing

The Association Between Non-vitamin K Antagonist Oral Anticoagulant Concentration and Clinical Outcomes.

Who this might be right for
Atrial Fibrillation
National Taiwan University Hospital 1,500
Testing effectiveness (Phase 2)Study completedNCT00252005
What this trial is testing

Oral Direct Factor Xa-inhibitor Apixaban in Patients With Acute Symptomatic Deep-vein Thrombosis-The Botticelli DVT Study

Who this might be right for
Deep-Vein Thrombosis
Bristol-Myers Squibb 520
Large-scale testing (Phase 3)Study completedNCT02740335
What this trial is testing

Study of Octaplex, a Four-factor Prothrombin Complex Concentrate (4F-PCC) and Beriplex® P/N (Kcentra) for the Reversal of Vitamin K Antagonist (VKA) Induced Anticoagulation in Patients Needing Urgent Surgery With Significant Bleeding Risk.

Who this might be right for
Significant Bleeding Risk
Octapharma 208
Not applicableActive Not RecruitingNCT04226547
What this trial is testing

Amplatzer Amulet LAAO vs. NOAC

Who this might be right for
Atrial FibrillationStrokeBleeding
Abbott Medical Devices 2,650
Large-scale testing (Phase 3)Study completedNCT02866838
What this trial is testing

Treatment of Intracerebral Hemorrhage in Patients on Non-vitamin K Antagonist

Who this might be right for
Intracerebral Hemorrhage
University Hospital, Basel, Switzerland 64
Post-approval studies (Phase 4)Study completedNCT02610933
What this trial is testing

Effect on Vascular Calcification of Replacing Warfarin by Rivaroxaban With or Without VitK2 in Hemodialysis Patients

Who this might be right for
Vascular Calcification
Onze Lieve Vrouw Hospital 117
Large-scale testing (Phase 3)Study completedNCT00062803
What this trial is testing

SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism

Who this might be right for
Pulmonary Embolism
Sanofi
Next Page